Under the agreement, the company with Mylan Pharma will market and sell two brands Ativan and Pacitane. The contract is for ...
The weight-loss drug market is heating up, with Swiss company Roche making a bold move by acquiring Carmot Therapeutics for up to $3.1 billion in 2023. This investment is aimed at accelerating its ...
These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.
Chuck Hardwick, the Kentucky-born son of a Wonder Bread maintenance worker who became a significant force in New Jersey ...
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
Once people don’t have justifiable access to medicine, the disease will stay longer with those people. Some will end up dying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results